Table 1 Baseline characteristics of the patients in the refractory and non-refractory groups
Baseline characteristics | Refractory (n = 172) | Non-refractory (n = 174) | P value |
|---|---|---|---|
Age, year | 31 (26–42) | 38 (28–47) | < 0.001 |
Female sex, n (%) | 131 (76.2%) | 135 (77.6%) | 0.754 |
Current smoking, n (%) | 22 (12.8%) | 14 (8.05%) | 0.148 |
GD family history, n (%) | 18 (10.3%) | 18 (10.5%) | 0.971 |
GO, n (%) | 56 (32.6%) | 29 (16.7%) | < 0.001 |
Initial goiter size (cm3) | 20.5 (15.1–29.4) | 16.7 (11.0–23.3) | < 0.001 |
Initial fT3 (pmol/L) | 27.6 (15.3–40.1) | 22.5 (15.5–33.0) | 0.008 |
Initial fT4 (pmol/L) | 70.3 (44.3–100.0) | 57.5 (41.9–90.4) | 0.021 |
Initial TSH (mIU/L) | 0.005 (0.005–0.005) | 0.005 (0.005–0.005) | 0.564 |
Initial TPOAb (IU/mL) | 166.4 (22.9–352.4) | 100.1 (18.6–289.2) | 0.128 |
Initial TgAb (IU/mL) | 199.1 (26.4–497.6) | 232.4 (32.5–493.3) | 0.767 |
Initial TRAb (IU/L) | 15.1 (5.4–29.0) | 7.5 (3.9–15.2) | < 0.001 |